Symbol="CRBP"
AssetType="Common Stock"
Name="Corbus Pharmaceuticals Holding"
Description="Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of novel therapies that target the endocannabinoid system in the fields of autoimmunity, fibrosis, and cancer. The company is headquartered in Norwood, Massachusetts."
CIK="1595097"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="100 RIVER RIDGE DRIVE, NORWOOD, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="29103200"
EBITDA="-42866164"
PERatio="None"
PEGRatio="0"
BookValue="3.905"
DividendPerShare="0"
DividendYield="0"
EPS="-11.63"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.37"
ReturnOnEquityTTM="-1.305"
RevenueTTM="0"
GrossProfitTTM="-16136826"
DilutedEPSTTM="-11.63"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="71"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="163.32"
PriceToBookRatio="0.37"
EVToRevenue="8.26"
EVToEBITDA="0.776"
Beta="2.329"
num_52WeekHigh="13.17"
num_52WeekLow="2.11"
num_50DayMovingAverage="8.43"
num_200DayMovingAverage="5.91"
SharesOutstanding="4409600"
DividendDate="None"
ExDividendDate="None"
symbol="CRBP"
open="6.41"
high="6.69"
low="6.41"
price="6.60"
volume="11026.00"
latest_trading_day="2023-07-28"
previous_close="6.41"
change="0.19"
change_percent="2.9641%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="25"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="75"
Volume_recent_avg="284497"
Change_recent_avg="0.04"
Delta_recent_avg="0.85"
Variance_recent_avg="0.43"
Change_ratio_recent_avg="0.35"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="75"
Aroon_momentum_negative="25"
image_negative_thumbnail_id_1="1162"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0196.jpeg"
image_negative_thumbnail_id_2="1139"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0172.jpeg"
image_neutral_thumbnail_id_1="534"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0065.jpeg"
image_neutral_thumbnail_id_2="571"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0028.jpeg"
image_positive_thumbnail_id_1="1004"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0166.jpeg"
image_positive_thumbnail_id_2="699"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0009.jpeg"
image_professor_thumbnail_id_1="1169"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
image_professor_thumbnail_id_2="1202"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
